Q4 2018 Holdings
Filed 2019-02-14 | 50 holdings | $37.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Aclaris Therapeutics Inc(ACRS) | COM | 00461U105 | $13.9M | 1,877,502 | 36.7% |
| Catalyst Pharmaceuticals Inc(CPRX) | COM | 14888U101 | $12.0M | 6,268,298 | 31.9% |
| Adma Biologics Inc(ADMA) | COM | 000899104 | $10.1M | 4,226,077 | 26.7% |
| Alphatec Holdings Inc(ATEC) | COM NEW | 02081G201 | $1.0M | 449,585 | 2.7% |
| Spdr S&P 500 ETF TR(SPY)Put | TR UNIT | 78462F103 | $174.9K | 700,000 | 0.5% |
| Iovance Biotherapeutics Inc(IOVA) | COM | 462260100 | $52.7K | 5,951,153 | 0.1% |
| Spdr Series Trust(XBI)Put | S&P BIOTECH | 78464A870 | $50.2K | 700,000 | 0.1% |
| Tesaro Inc | COM | 881569107 | $32.8K | 442,219 | 0.1% |
| Nevro Corp(NVROEUR) | COM | 64157F103 | $29.0K | 744,415 | 0.1% |
| Aratana Therapeutics Inc(PETXEUR) | COM | 03874P101 | $25.0K | 4,083,135 | 0.1% |
| Tesaro IncCall | COM | 881569107 | $24.1K | 325,000 | 0.1% |
| Retrophin Inc | COM | 761299106 | $23.0K | 1,016,114 | 0.1% |
| Adamas Pharmaceuticals Inc(ADMSEUR) | COM | 00548A106 | $22.3K | 2,614,468 | 0.1% |
| Dexcom Inc(DXCM) | COM | 252131107 | $21.6K | 179,900 | 0.1% |
| Zogenix Inc | COM NEW | 98978L204 | $19.5K | 535,998 | 0.1% |
| LA Jolla Pharmaceutical Co(LJPC) | COM PAR $.0001 2 | 503459604 | $18.4K | 1,947,541 | 0.0% |
| Biodelivery Sciences Intl in(BDSIUSD) | COM | 09060J106 | $16.2K | 4,375,066 | 0.0% |
| Recro Pharma Inc | COM | 75629F109 | $14.5K | 2,048,025 | 0.0% |
| Global Blood Therapeutics inCall | COM | 37890U108 | $14.4K | 350,000 | 0.0% |
| Strongbridge Biopharma PLC | SHS USD | G85347105 | $12.6K | 2,821,722 | 0.0% |
| Nevro Corp(NVROEUR)Call | COM | 64157F103 | $11.7K | 300,000 | 0.0% |
| Incyte Corp(INCY) | COM | 45337C102 | $11.7K | 183,300 | 0.0% |
| Nanostring Technologies Inc(NSTGEUR) | COM | 63009R109 | $10.7K | 720,600 | 0.0% |
| Quotient LTD | SHS | G73268107 | $10.4K | 1,697,582 | 0.0% |
| Global Blood Therapeutics in | COM | 37890U108 | $9.9K | 240,909 | 0.0% |
| Antares Pharma Inc(ATRSEUR) | COM | 036642106 | $9.4K | 3,444,147 | 0.0% |
| Integra Lifesciences Hldgs C(IART) | COM NEW | 457985208 | $8.9K | 196,572 | 0.0% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $8.5K | 200,000 | 0.0% |
| Intersect ENT Inc | COM | 46071F103 | $8.1K | 287,900 | 0.0% |
| Avadel Pharmaceuticals PLC | SPONSORED ADR | 05337M104 | $8.0K | 3,102,673 | 0.0% |
| Sierra Oncology Inc | COM | 82640U107 | $6.4K | 4,880,327 | 0.0% |
| Alexion Pharmaceuticals Inc(ALXN) | COM | 015351109 | $5.7K | 58,700 | 0.0% |
| Strata Skin Sciences Inc | COM NEW | 86272A206 | $5.6K | 2,171,363 | 0.0% |
| Viewray Inc(VRAYQ) | COM | 92672L107 | $5.3K | 866,500 | 0.0% |
| SOL GEL Technologies(SLGL) | SHS | M8694L103 | $5.1K | 847,700 | 0.0% |
| Biohaven Pharmactl Hldg Co L(BHVN) | COM | G11196105 | $4.8K | 129,300 | 0.0% |
| Livanova PLC(LIVN) | SHS | G5509L101 | $4.7K | 51,000 | 0.0% |
| Optinose Inc | COM | 68404V100 | $4.4K | 710,600 | 0.0% |
| Neos Therapeutics Inc(NEOS) | COM | 64052L106 | $4.3K | 2,618,819 | 0.0% |
| Osmotica Pharmaceuticals PLC | SHS | G6S41R101 | $4.1K | 528,571 | 0.0% |
| Teligent Inc New | COM | 87960W104 | $3.9K | 2,823,383 | 0.0% |
| Tandem Diabetes Care Inc(TNDM) | COM NEW | 875372203 | $3.4K | 89,100 | 0.0% |
| Vericel Corp(VCEL) | COM | 92346J108 | $3.3K | 190,000 | 0.0% |
| Heron Therapeutics Inc(HRTX) | COM | 427746102 | $3.1K | 119,294 | 0.0% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $2.8K | 143,129 | 0.0% |
| Dova Pharmaceuticals Inc(DOVA) | COM | 25985T102 | $2.7K | 351,800 | 0.0% |
| Kala Pharmaceuticals Inc | COM | 483119103 | $1.7K | 339,119 | 0.0% |
| Eiger Biopharmaceuticals Inc(CLDNEUR) | COM | 28249U105 | $1.5K | 143,300 | 0.0% |
| Idera Pharmaceuticals Inc | COM PAR | 45168K405 | $1.3K | 486,604 | 0.0% |
| Novelion Therapeutics Inc | COM NEW | 67001K202 | $1.0K | 1,229,301 | 0.0% |